These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
3. Beta-blockers and diabetes: the bad guys come good. Cruickshank JM Cardiovasc Drugs Ther; 2002 Sep; 16(5):457-70. PubMed ID: 12652116 [TBL] [Abstract][Full Text] [Related]
4. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. Yusuf S; Lessem J; Jha P; Lonn E J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243 [TBL] [Abstract][Full Text] [Related]
5. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367 [TBL] [Abstract][Full Text] [Related]
7. The beta 1 hyperselectivity in beta-blocker treatment. Cruickshank JM J Cardiovasc Pharmacol; 1995; 25 Suppl 1():S35-46. PubMed ID: 7752668 [TBL] [Abstract][Full Text] [Related]
8. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man. Lemmer B Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770 [TBL] [Abstract][Full Text] [Related]
9. The case for beta-blockers as first-line antihypertensive therapy. Cruickshank JM J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111 [TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Chen JM; Heran BS; Perez MI; Wright JM Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622 [TBL] [Abstract][Full Text] [Related]
14. Are we misunderstanding beta-blockers. Cruickshank JM Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471 [TBL] [Abstract][Full Text] [Related]
15. The use of beta-blockers after myocardial infarction. Turi ZG; Braunwald E JAMA; 1983 May; 249(18):2512-6. PubMed ID: 6133014 [TBL] [Abstract][Full Text] [Related]
16. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Singh BN Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400 [TBL] [Abstract][Full Text] [Related]
17. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. Bangalore S; Sawhney S; Messerli FH J Am Coll Cardiol; 2008 Oct; 52(18):1482-9. PubMed ID: 19017516 [TBL] [Abstract][Full Text] [Related]
18. [Antianginal and antiadrenergic therapy in acute coronary syndrome]. Raos V; Bergovec M Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers. Pearle DL Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155 [TBL] [Abstract][Full Text] [Related]
20. Beta-blocker underuse in secondary prevention of myocardial infarction. Everly MJ; Heaton PC; Cluxton RJ Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]